Sentence examples for given malignancy from inspiring English sources

In some contexts, as many as 25,000 cells contribute to a given malignancy following tail vein injection, and, consequently, nearly 25,000 loss of function phenotypes can be screened in the context of an individual mouse.

In addition, we discuss how MOA-based PD biomarker analyses can be used both as patient selection diagnostic tools and for designing novel drug combinations targeting the specific mutational signature of a given malignancy.

Disease stage is used not only for prognostic stratification within groups of patients with a given malignancy, but also for determining the most appropriate treatment.

To score for external validity, we created an index that summed the number of species and models tested for a given malignancy and awarded an extra point if more than one species and model was tested.

Despite the qualitative variability of stiffness within and adjacent to a given malignancy on a single acquisition, quantitative assessment of maximum and median elasticity were highly reliable across multiple SWE acquisitions.

24 25262728293229 32 Given these malignancy differences in RA patients, an RA cohort represents a more appropriate comparator for evaluating the malignancy risk of specific RA interventions than the general population.

Combining studies would increase the power for a given hematological malignancy subtype, but the heterogeneity would also have increased.

Evaluate current accepted risk factors for well-differentiated thyroid carcinoma, and develop a predictive model to determine one's risk of malignancy given a thyroid nodule.

Our aim was to retrospectively estimate feasibility, safety, and efficacy of the laparoscopic approach in the setting of gynecologic malignancy, given the high incidence of earlier abdominal surgery and pelvic radiation treatment in this select population.

Patients with hematologic malignancy given a preparative regimen of cyclophosphamide (120 mg/kg) and 15.75 Gy fractionated total body irradiation (TBI) had a 27% cumulative incidence of graft failure, which was less than the 69% incidence seen previously in patients given cyclophosphamide and 12.0 Gy fractioned TBI (p < 0.05, log-rank test).

Given the known malignancy risk with systemic immune suppressants (which increases with the intensity and duration of immune suppression) [ 47, 48], these results were not unexpected.